10 /100
LOW RISK
Score updated Jul 13, 2026

ALAB — Astera Labs, Inc. Dilution Risk Tracker

Track ALAB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ALAB — Get alerts when the score changes →

As of July 13, 2026, Astera Labs, Inc. (ALAB) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Astera Labs, Inc. has a market capitalization of $58.77B, 171.41M shares outstanding, 712 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ALAB.
🔔 Track ALAB — Get forecast alerts →

💹 Market Data

Market Cap$58.77B
Shares Outstanding171.41M
Float153.44M
Cash$148.28M
Debt$41.85M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 10.6% shares (2026Q1 vs prior)
712 institutional holders · 152.35M shares
#1 FMR LLC 25.53M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 12.68M shares
#3 BlackRock, Inc. 11.45M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest12.68M
Days to Cover1.7
% of Float8.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Mar 19, 2026
4 INSIDER TRANSACTION Mar 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ALAB Shareholders

Astera Labs, Inc. (ALAB) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for ALAB shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ALAB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ALAB alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ALAB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ALAB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ALAB
📊 ALAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ALAB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.